A new protagonist could enter the wellness and natural medicine industry: it is called Umlaut micrantha and is a shrub native to Brazil. Surprisingly, this plant commonly considered a weed, has turned out to be rich in cannabidiol (CBD), one of the most studied and appreciated active ingredients for its relaxing, anti-inflammatory and analgesic effects.
The discovery comes from a team of researchers from the Federal University of Rio de Janeiro, led by the molecular biologist Rodrigo Moura Net, which detected the presence of CBD inside Trema micrantha, but without any trace of THC, the psychotropic compound typical of cannabis.
A “relative” of cannabis, but without psychotropic effects
Trema micrantha is not just any plant: it belongs to the same botanical family as cannabis, that of cannabaceae. It grows wild in various tropical and subtropical areas of the world – from Brazil to Mexico, to Jamaica – and is also known as “Florida dodder”. For years it was ignored or removed as a simple weed, but its chemical composition today puts it in a new light.
Its most interesting feature? Contains CBD but no THC, which makes it free from psychotropic effects and potentially exempt from the regulatory restrictions that still limit cannabis in many regions of the world.
It might interest you
A New Resource for the CBD Industry
From the cultivation point of view, Trema micrantha has numerous advantages: rapid growth, climate resistance e environmental adaptability. It is a plant that grows easily and in large quantities, making it perfect for large-scale production.
Furthermore, since it is not associated with the problems related to cannabis, it could offer a simplest and most sustainable solution for CBD extractionThis opportunity could be of interest not only to the wellness market but also to the therapeutic products market, where demand for THC-free alternatives is constantly growing.
New perspectives for natural medicine
The discovery has already received attention and support from the Brazilian government, which financed the project with 500.000 reais (about 104.000 dollars) to further research and optimize the extraction processes of the active ingredient. The goal is to evaluate the effectiveness of Trema micrantha in treatments currently entrusted to therapeutic cannabis, such as in the case of chronic pain or some neurological pathologies.
In this scenario, the use of Trema micrantha could complement — and in some cases even replace — already known products such aslegal weed, helping to diversify the offering and alleviate the problems related to regulatory restrictions.
Comments (1)
It is interesting that a plant considered a weed can have beneficial health properties. However, I wonder if there are more in-depth studies on the long-term side effects of Trema micrantha, especially for those with allergies.